| Lancet conference: influenza in the Asia-Pacific and the international scientific symposium on influenza pandemic response and preparedness. | |
| | |
MedLine Citation:
|
PMID: 19968508 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Lancet Conference on Influenza in the Asia-Pacific was held back-to-back with the International Scientific Symposium on Influenza A (H1N1) Pandemic Response and Preparedness organized by the Ministry of Health, People's Republic of China, with support from the WHO. The conference has attracted scientists and clinicians from different parts of the world to share the most updated information on the current influenza pandemic, as well as key issues on seasonal influenza that are relevant to pandemic response. Several highlights are described here. |
| | |
Authors:
|
Paul K S Chan |
Related Documents
:
|
19943218 - International generic pharmaceutical alliance - 12th annual conference. part 2. 22182138 - Berseneva, krasheninnikov, and nieminen reply:. 20559698 - Special issue: select papers from the 29th northern ireland biomedical engineering conf... 20622888 - To name or not to name? an overview of the social and ethical issues raised by removing... 20183558 - Why we disagree to disagree: a reply to commentaries by robertson and mcgilly, and lind... |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Expert review of anti-infective therapy Volume: 7 ISSN: 1744-8336 ISO Abbreviation: Expert Rev Anti Infect Ther Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-12-08 Completed Date: 2010-02-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101181284 Medline TA: Expert Rev Anti Infect Ther Country: England |
Other Details:
|
Languages: eng Pagination: 1165-6 Citation Subset: IM |
Affiliation:
|
Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China. paulkschan@cuhk.edu.hk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Asia China Disease Outbreaks* Drug Resistance, Viral Humans Influenza A Virus, H1N1 Subtype / drug effects, immunology, pathogenicity Influenza Vaccines / therapeutic use Influenza, Human / epidemiology*, immunology, prevention & control World Health World Health Organization |
| Chemical | |
Reg. No./Substance:
|
0/Influenza Vaccines |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individu...
Next Document: 49th ICAAC Annual Meeting: optimization of anti-infective use in the clinical setting.